1. Home
  2. ABCL vs BDC Comparison

ABCL vs BDC Comparison

Compare ABCL & BDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

N/A

Current Price

$12.19

Market Cap

4.1B

Sector

Health Care

ML Signal

N/A

Logo Belden Inc

BDC

Belden Inc

N/A

Current Price

$105.73

Market Cap

4.1B

ML Signal

N/A

Company Overview

Basic Information
Metric
ABCL
BDC
Founded
2012
1902
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
4.1B
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
ABCL
BDC
Price
$12.19
$105.73
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
5
Target Price
$16.82
★ $151.20
AVG Volume (30 Days)
★ 4.3M
317.9K
Earning Date
11-09-2026
10-29-2026
Dividend Yield
N/A
★ 0.19%
EPS Growth
10.91
★ 23.13
EPS
N/A
★ 2.75
Revenue
$75,128,000.00
★ $2,715,194,000.00
Revenue This Year
N/A
$24.20
Revenue Next Year
$7.12
$17.18
P/E Ratio
★ N/A
$35.14
Revenue Growth
★ 160.56
10.33
52 Week Low
$2.75
$96.06
52 Week High
$14.98
$159.99

Technical Indicators

Market Signals
Indicator
ABCL
BDC
Relative Strength Index (RSI) 48.43 46.42
Support Level $11.78 $102.41
Resistance Level $12.88 $115.40
Average True Range (ATR) 0.83 4.47
MACD 0.01 0.54
Stochastic Oscillator 40.11 78.84

Price Performance

Historical Comparison
ABCL
BDC

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

About BDC Belden Inc

Belden Inc is a supplier of complete connection solutions. It has two segments, Smart Infrastructure Solutions and Automation Solutions. Smart Infrastructure Solutions provides network infrastructure and broadband solutions, serving markets such as data centers, government, healthcare, and broadband and wireless service providers, with products including copper and fiber cable and connectivity solutions. Automation Solutions provides digitization and automation solutions that enable IT OT convergence and support acquisition, transmission, orchestration, and management, serving markets including Warehousing and Logistics, Energy, Transportation, and Discrete Manufacturing. The company operates in the Americas, EMEA, and APAC, with maximum revenue coming from the Americas.

Share on Social Networks: